“We believe the Broad’s overall financial and enterprise profile is sound, with a strong base of grant awards from government and nongovernment sources and robust philanthropic support,” said S&P analyst Charlene Butterfield.
The outlook is stable, reflecting S&P’s view of the Broad Institute’s ability to continue to generate positive operations.
S&P also affirmed the “AA-” long-term rating on the Broad Institute’s series 2011A and 2011B bonds.
More articles on healthcare finance:
Envision Healthcare joins S&P 500 post merger
Ohio county outlines new ambulance billing rates: 4 things to know
NY physicians group picks Dimensional Insight’s analytics platform
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
